HomeLBPH • NASDAQ
add
Longboard Pharmaceuticals Inc
Previous close
$20.60
Day range
$20.37 - $22.51
Year range
$3.60 - $28.15
Market cap
857.11M USD
Avg Volume
378.19K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Financials
Income Statement
Revenue
Net income
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 15.57M | 32.80% |
Net income | -15.03M | -32.51% |
Net profit margin | — | — |
Earnings per share | -0.62 | 6.06% |
EBITDA | -15.57M | -32.80% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 48.50M | -28.25% |
Total assets | 50.70M | -28.21% |
Total liabilities | 9.77M | 6.87% |
Total equity | 40.92M | — |
Shares outstanding | 36.02M | — |
Price to book | 12.34 | — |
Return on assets | -71.07% | — |
Return on capital | -82.88% | — |
Cash Flow
Net change in cash
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Net income | -15.03M | -32.51% |
Cash from operations | -11.03M | -14.03% |
Cash from investing | -1.56M | -172.77% |
Cash from financing | 3.01M | 777.93% |
Net change in cash | -9.58M | -20.19% |
Free cash flow | -5.31M | 10.04% |
About
Founded
2020
Headquarters
Website
Employees
50